Signature of circular RNAs in peripheral blood mononuclear cells from patients with active tuberculosis.
Biomarkers
/ metabolism
Case-Control Studies
Cells, Cultured
Computational Biology
/ methods
Gene Ontology
Humans
Leukocytes, Mononuclear
/ metabolism
MicroRNAs
/ metabolism
Oligonucleotide Array Sequence Analysis
/ methods
Proto-Oncogene Proteins c-akt
/ metabolism
RNA, Circular
/ metabolism
ROC Curve
Tuberculosis
/ metabolism
active tuberculosis
biomarkers
circRNAs
peripheral blood mononuclear cells
signalling pathway
Journal
Journal of cellular and molecular medicine
ISSN: 1582-4934
Titre abrégé: J Cell Mol Med
Pays: England
ID NLM: 101083777
Informations de publication
Date de publication:
03 2019
03 2019
Historique:
received:
17
09
2018
revised:
13
11
2018
accepted:
22
11
2018
pubmed:
20
12
2018
medline:
26
6
2020
entrez:
20
12
2018
Statut:
ppublish
Résumé
The study was to characterize the expression profiles of circular RNAs (circRNAs) in peripheral blood mononuclear cells (PBMCs) from active tuberculosis (TB) patients and to investigate their function. Microarray was applied to detect circRNA expression and reverse transcription-quantitative polymerase chain reaction was conducted to validate the microarray results. Meanwhile, receiver operating characteristic curve (ROC) curve was calculated to evaluate the predictive power of the selected circRNAs for TB diagnosis. Additionally, circRNA/miRNA interaction was predicted based on miRNA target prediction software, and gene ontology as well as Kyoto Encyclopedia of Genes and Genomes pathway analysis were used to predict their biological function. In total, 171 circRNAs were found to be dysregulated in TB samples. Specifically, circRNA_103017, circRNA_059914 and circRNA_101128 were confirmed to be increased, while circRNA_062400 was decreased in TB samples. ROC analysis revealed that circRNA_103017 had potential value for TB diagnosis, followed by circRNA_059914 and circRNA_101128. Moreover, circRNA_101128 expression in TB samples was negatively correlated with the level of its possible target let-7a and bioinformatics analysis showed that circRNA_101128 was potentially involved in MAPK and P13K-Akt pathway possibly via modulation of let-7a. Taken together, our results indicated that some dysregulated circRNAs were potential biomarkers for the diagnosis of TB and circRNA_101128-let-7a interplay may play considerable role in PBMCs response to Mtb infection.
Identifiants
pubmed: 30565391
doi: 10.1111/jcmm.14093
pmc: PMC6378186
doi:
Substances chimiques
Biomarkers
0
MicroRNAs
0
RNA, Circular
0
Proto-Oncogene Proteins c-akt
EC 2.7.11.1
Banques de données
GENBANK
['GSE117563']
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1917-1925Informations de copyright
© 2018 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.
Références
Mol Immunol. 2017 Oct;90:264-272
pubmed: 28846924
Cancer Lett. 2018 Aug 28;430:179-192
pubmed: 29803789
Int J Infect Dis. 2017 Jun;59:110-117
pubmed: 28416440
Lancet. 2017 Jul 15;390(10091):324-332
pubmed: 28139255
Nat Commun. 2017 Mar 06;8:14642
pubmed: 28262681
Mol Genet Metab. 2015 Dec;116(4):269-74
pubmed: 26527160
Nat Commun. 2018 Jul 16;9(1):2733
pubmed: 30013160
Sci Rep. 2018 Feb 5;8(1):2375
pubmed: 29403024
Cell Host Microbe. 2015 Mar 11;17(3):345-356
pubmed: 25683052
Blood Cancer J. 2016 Oct 14;6(10):e483
pubmed: 27740630
J Pathog. 2016;2016:8623825
pubmed: 27999684
Onco Targets Ther. 2018 Jul 10;11:3979-3987
pubmed: 30022841
Int J Mol Med. 2018 May;41(5):2885-2892
pubmed: 29436601
Microbiol Immunol. 2016 Apr;60(4):215-27
pubmed: 26876933
J Cell Mol Med. 2018 Sep;22(9):4076-4084
pubmed: 29961269
Cell Physiol Biochem. 2018;45(3):1230-1240
pubmed: 29448254
BMC Cancer. 2017 Mar 16;17(1):201
pubmed: 28302118
Science. 2017 Sep 22;357(6357):
pubmed: 28798046
BMC Microbiol. 2014 Feb 12;14:37
pubmed: 24521422
EBioMedicine. 2018 Jan;27:18-26
pubmed: 29248507
J Cell Mol Med. 2019 Mar;23(3):1917-1925
pubmed: 30565391
Mol Cell. 2017 Jul 20;67(2):214-227.e7
pubmed: 28625552
Oncotarget. 2017 Nov 27;8(69):113571-113582
pubmed: 29371930
Med Sci Monit. 2018 Apr 24;24:2497-2507
pubmed: 29686222
BMC Genet. 2017 Dec 02;18(1):100
pubmed: 29197342
Biochem Biophys Res Commun. 2016 Feb 26;471(1):52-6
pubmed: 26845359